Cancer Biomarkers Market Size 2021 | To Exhibit 12.4 % CAGR and Hit USD 48.20 Billion by 2026
01 avr. 2021 09h32 HE
|
Fortune Business Insights
Pune, India, April 01, 2021 (GLOBE NEWSWIRE) -- The global cancer biomarkers market size is forecast to reach USD 48.20 billion by 2026 on account of the increasing popularity of personalized...
Global Cancer Biomarkers Market Size to Grow at 12.4 % CAGR and Hit USD 48.20 Billion by 2026; Market to Witness Remarkable Growth Owing to Increasing Prevalence of Cancer Worldwide | Fortune Business Insights™
26 févr. 2021 04h24 HE
|
Fortune Business Insights
Pune, India, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The global cancer biomarkers market size is forecast to reach USD 48.20 billion by 2026 on account of the increasing popularity of personalized...
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26 sept. 2019 09h29 HE
|
Pressure BioSciences, Inc.
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA,...
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication
10 sept. 2018 08h18 HE
|
Biodesix, Inc.
BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing the noninvasive BDX-XL2 test, currently in development, could reduce the number of...
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
20 mars 2018 09h00 HE
|
Biodesix, Inc.
BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate...
Huge R&D Investments Bodes Well for Cancer Tissue Diagnostics Market - Future Market Insights
27 nov. 2017 05h48 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
Valley Cottage, New York, Nov. 27, 2017 (GLOBE NEWSWIRE) -- While cancer continues to be among the primary chronic diseases across the world, a number of companies have been investing on the...
Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients
07 nov. 2017 12h22 HE
|
Biodesix, Inc.
BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix® chief technology officer, Dr. Heinrich Roder, will give an oral presentation discussing a proprietary test development methodology that...
Biodesix To Present Data at SITC Annual Meeting
25 oct. 2017 10h00 HE
|
Biodesix, Inc.
BOULDER, Colo., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Biodesix will conduct an oral presentation on immunotherapy biomarkers in addition to presenting data from two separate studies at the SITC 2017...
OncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016
16 mars 2016 16h30 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) will present new data related to its clinical and preclinical anti-cancer stem cell and...